Search Results - "NOE, Les"

Reimbursement and economic factors influencing dialysis modality choice around the world by Just, Paul M., de Charro, Frank Th, Tschosik, Elizabeth A., Noe, Les L., Bhattacharyya, Samir K., Riella, Miguel C.

“…The worldwide incidence of kidney failure is on the rise and treatment is costly; thus, the global burden of illness is growing. Kidney failure patients…”
Get full text

Budget Impact Analysis of Tapentadol Extended Release for the Treatment of Moderate to Severe Chronic Noncancer Pain by Merchant, Sanjay, PhD, Noe, Les L., MPA, RPh, Howe, Andrew, PharmD, Duff, Steve, MS, Gricar, Joe, MS, Ogden, Kristine, BS, Mody, Samir H., PharmD, MBA

“…Abstract Background Opioids are commonly used to manage chronic pain. Although traditional μ-opioids are effective in reducing pain, they are often associated…”
Get full text

Economic evaluations of peritoneal dialysis and hemodialysis: 2004-2012 [version 1; peer review: 1 approved, 1 approved with reservations] by Liu, Frank Xiaoqing, Quock, Tiffany P, Burkart, John, Noe, Les L, Inglese, Gary

“…Background: End-stage renal disease (ESRD) is a debilitating condition resulting in death unless treated. Treatment options include conservative care,…”
Get full text

Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: A 2-week, multicenter, randomized, open-label study by Donohue, James F., MD, Hanania, Nicola A., MD, Ciubotaru, Ronald L., MD, Noe, Les, MPA, Pasta, David J., MS, Schaefer, Kendyl, MSc, Claus, Raymond, MS, Andrews, William T., MD, Roach, James, MD

“…Abstract Background: The National Heart, Lung, and Blood Institute guideline recommends that dosing racemic albuterol be administered every 1 to 4 hours for…”
Get full text

Impact of solifenacin on quality of life, medical care use, work productivity, and health utility in the elderly: an exploratory subgroup analysis by Zinner, Norman, Noe, Les, Rasouliyan, Lawrence, Marshall, Thomas, Runken, M Christopher, Seifeldin, Raafat

“…Overactive bladder (OAB) is a common problem among the elderly and a financial burden to society. The prevalence of OAB increases with age and affects > or =…”
Get more information

QOLP-31. ASSESSING THE IMPACT OF GLIOBLASTOMA ON WORK PRODUCTIVITY IN PATIENTS AND THEIR CAREGIVERS by Armstrong, Terri, Puduvalli, Vinay, Walbert, Tobias, Peters, Katherine, Loughan, Ashlee, Ahluwalia, Manmeet, Province Warren, Paula, Cachia, David, Taylor, Jennie, O Blakeley, Jaishri, Ganguli, Arijit, Khandelwal, Nikhil, Kamalakar, Rajesh, Noe, Les, Kumthekar, Priya

“…Abstract Information is limited on the impact of glioblastoma (GBM) on patient employment and caregiver time commitments. This observational multisite study…”
Get full text

QOLP-20. IMPACT OF GLIOBLASTOMA ON PATIENT-REPORTED SYMPTOM BURDEN AND PHYSICAL ACTIVITY ASSESSED BY CONVENTIONAL INSTRUMENTS AND A NOVEL DEVICE–BASED TECHNOLOGY by Armstrong, Terri, Puduvalli, Vinay, Walbert, Tobias, Peters, Katherine, Loughan, Ashlee, Ahluwalia, Manmeet, Province Warren, Paula, Cachia, David, Taylor, Jennie, O Blakeley, Jaishri, Ganguli, Arijit, Khandelwal, Nikhil, Kamalakar, Rajesh, Noe, Les, Kumthekar, Priya

“…Abstract Glioblastoma (GBM) is a rapidly progressing disease associated with significant deterioration in quality of life. This study evaluated clinical…”
Get full text

Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ER by Zinner, Norman, Noe, Les, Rasouliyan, Lawrence, Marshall, Thomas, Seifeldin, Raafat

“…ABSTRACT Objective: Assess changes in resource utilization, work and activity impairment, and health utility among OAB patients continuing to have urgency…”
Get full text

Comparison of Levalbuterol and Racemic Albuterol in Hospitalized Patients with Acute Asthma or COPD : A 2-Week, Multicenter, Randomized, Open-Label Study: Asthma and Related Disorders by DONOHUE, James F, HANANIA, Nicola A, CIUBOTARU, Ronald L, NOE, Les, PASTA, David J, SCHAEFER, Kendyl, CLAUS, Raymond, ANDREWS, William T, ROACH, James

Get full text

The implications of poor medication persistence with treatment for overactive bladder by Noe, Les, Sneeringer, Robyn, Patel, Bimal, Williamson, Todd

“…Overactive bladder (OAB) affects more than 17 million Americans and accounts for more than dollar 12 billion annually in health care costs. To stem the costs…”
Get more information

A Pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure by Noe, Les L., Vreeland, Mary Glenn, Pezzella, Stephen M., Trotter, Jeffrey P.

“…The management of patients with congestive heart failure (CHF) can place a significant economic burden on managed care organizations, leading providers to seek…”
Get full text

The cost effectiveness of tamoxifen in the prevention of breast cancer by Noe, L L, Becker, 3rd, R V, Gradishar, W J, Gore, M, Trotter, J P

“…In the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial (BCPT), women considered to be at high risk for developing breast…”
Get full text